HROWM Projected Dividend Yield

Sr Nt/Harrow Health Inc ( NASDAQ : HROWM )

Harrow Health is an ophthalmic-focused pharmaceutical company. Co. engages in the development, production, sale and distribution of prescription medications. Co. owns and operates ImprimisRx, the ophthalmology-focused pharmaceutical-compounding business, and its branded drugs are marketed under its Harrow name. In addition, Co. also has non-controlling equity positions in Surface Ophthalmics, Inc., which is focused on development and commercialization of therapeutics for ocular surface diseases; and Melt Pharmaceuticals, Inc., which is focused on the development and commercialization of proprietary non-intravenous, sedation and anesthesia therapeutics for human medical procedures.

11 YEAR PERFORMANCE RESULTS

HROWM Dividend History Detail
HROWM Dividend News
HROWM Competitors News
# of Shares: 0 Closing Price: 26.44 Current Market Value: 0.00 Cost Basis: 0.00 Date Acquired:
Dividend Cash Flow
Year Annual Dividend Dividend Growth # of Shares Annual Dividend Income Yield On Cost %
2023 2.56 0% 0 $ 0.00 0.00%
2024 2.97 0% 0 $ 0.00 11.23%
2025 2.97 0% 0 $ 0.00 11.23%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 11.23%
Rolling Last 4 qtrs dividends total $ 2.97 and Previous last 4 qtrs dividends total $ 0.34
Dividend 1 Yr Growth = ( 2.97 – 0.34 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection)
0.34
Year
Declaration Date
Ex-Dividend Date
Record Date
Payable Date
Dividend $ Amount
2024
Apr 03, 2024
Apr 12, 2024
Apr 15, 2024
Apr 30, 2024
0.7422
2024
Jan 03, 2024
Jan 11, 2024
Jan 15, 2024
Jan 31, 2024
0.7422
2024 Total:
1.4844
2023
Oct 06, 2023
Oct 12, 2023
Oct 15, 2023
Oct 31, 2023
0.7422
2023
Jul 05, 2023
Jul 13, 2023
Jul 15, 2023
Jul 31, 2023
0.7422
2023
Apr 04, 2023
Apr 13, 2023
Apr 15, 2023
Apr 30, 2023
0.7422
2023
Jan 06, 2023
Jan 12, 2023
Jan 15, 2023
Jan 31, 2023
0.3381
2023 Total:
2.5647
X
Search Dividend Investor